Viagra could hold key to halting Peyronie's disease

Combining two widely prescribed drug classes could provide the first effective treatment for early-stage Peyronie's disease, according to a new study published in The Journal of Sexual Medicine.

Mpox study reveals that hidden infections may fuel spread

A Kaiser Permanente study of nearly 8,000 men shows that in mid- to late 2024, mpox was far more common than previously thought among men who had sex with men. Individuals without symptoms accounted for most infections and ...

Novel molecular marker may improve prostate cancer treatment

Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...

page 2 from 29